In a report released on March 7, Niraj Shah from Goldman Sachs maintained a Buy rating on ALS Ltd. (CPBLF – Research Report), with a price target of A$17.75. The company’s shares closed last ...
A new study helps determine which blood tests are best at identifying and monitoring ALS. The study is published in the February 26, 2025, online issue of Neurology ® , the medical journal of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback